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Abstract
The amyloid-b 42 (Ab42) is thought to play a central role in the pathogenesis of Alzheimer’s disease (AD). However, the
molecular mechanisms by which Ab42 induces neuronal dysfunction and degeneration remain elusive. Mitochondrial
dysfunctions are implicated in AD brains. Whether mitochondrial dysfunctions are merely a consequence of AD pathology,
or are early seminal events in AD pathogenesis remains to be determined. Here, we show that Ab42 induces mitochondrial
mislocalization, which contributes to Ab42-induced neuronal dysfunction in a transgenic Drosophila model. In the Ab42 fly
brain, mitochondria were reduced in axons and dendrites, and accumulated in the somata without severe mitochondrial
damage or neurodegeneration. In contrast, organization of microtubule or global axonal transport was not significantly
altered at this stage. Ab42-induced behavioral defects were exacerbated by genetic reductions in mitochondrial transport,
and were modulated by cAMP levels and PKA activity. Levels of putative PKA substrate phosphoproteins were reduced in
the Ab42 fly brains. Importantly, perturbations in mitochondrial transport in neurons were sufficient to disrupt PKA
signaling and induce late-onset behavioral deficits, suggesting a mechanism whereby mitochondrial mislocalization
contributes to Ab42-induced neuronal dysfunction. These results demonstrate that mislocalization of mitochondria
underlies the pathogenic effects of Ab42 in vivo.
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Introduction
Alzheimer’s disease (AD) is a progressive neurodegenerative
disease without effective therapies. Pathologically, AD is defined
by an extensive loss of neurons and by formation of two
characteristic protein deposits, extracellular amyloid plaques
(APs) and intracellular neurofibrillary tangles (NFTs). The major
components of APs and NFTs are the 40 or 42 amino acid
amyloid-b peptides (Ab40 or Ab42) and the hyperphosphorylated
microtubule associated protein tau, respectively [1].
Molecular genetic studies of early-onset familial AD patients have
identified causative mutations in genes encoding APP and
presenilins (PS1 and PS2), and these mutations increase Ab42
production and/or Ab aggregation [2]. Ab42 is highly toxic to
cultured neurons and causes memory deficits and neurodegenera-
tion in animal models overproducing human Ab42 [3]. Thus, Ab42
is thought to play a causative role in the pathogenesis of AD [4].
Several lines of evidence indicate that mitochondrial function is
impaired in the brains of AD patients [5,6,7,8]. Markedly reduced
levels of mitochondrial proteins and activities and increased
abnormal and damaged mitochondria have been reported in AD
brains [8,9,10,11]. Whether mitochondrial dysfunctions are
merely a consequence of AD pathology or are early seminal
events in AD pathogenesis remains to be determined.
In order to identify genes and pathways that are involved in
Ab42-induced toxicity in vivo, we are utilizing Drosophila as a model
system. To produce human Ab42 in the secretory pathway of fly
brain neurons, the Ab42 peptide sequence is directly fused to a
secretion signal peptide at the N-terminus. Using a GAL4-UAS
transgene expression system [12], Ab42 peptide was expressed in
the fly brain. Mass spectrometry analysis revealed that this
construct produces the intact Ab42 peptide in the fly brain
[13,14], and immuno-electron microscopy analysis showed that
expressed Ab42 was distributed in the secretory pathways in
neurons in the fly brains [14]. These Ab42 flies show late-onset,
progressive short-term memory defects, locomotor dysfunctions,
neurodegeneration, and premature death, accompanied by
formation of Ab42 deposits [13,14]. This or similar Drosophila
models have been used to study mechanisms underlying
neurotoxicity of Ab42 in vivo [3,15,16,17,18,19,20,21,22,23].
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Using this Drosophila model [13,14], here we have demonstrated
that mitochondrial mislocalization underlies the pathogenic effects
of Ab42 in vivo.
Results
Mitochondria Are Reduced in the Axons and Dendrites in
Ab42 Fly Brain
Using mito-GFP transgene, a reporter construct in which GFP
is fused to a mitochondrial targeting signal [24], we analyzed the
distribution of mitochondria in the Ab42 fly brain. For this
purpose, we focused on the mushroom body structure, where
axons, dendrites, and cell bodies can be easily identified in the fly
brain [25] (Figure 1A). Mito-GFP and Ab42 were expressed in all
neurons by the pan-neuronal elav-GAL4 driver.
The mito-GFP signal in the axons and dendrites of the
mushroom body structure was significantly decreased in the
Ab42 fly brains (Figure 1B). In contrast, the mito-GFP signal was
increased in the cell bodies of neurons (Figure 1B). These results
suggest that Ab42 does not cause global reduction of mitochon-
dria, but rather induces mitochondrial mislocalization. A signif-
icant reduction in mitochondria was observed in the axons at 5
days after eclosion (dae), while a reduction in mitochondria in the
dendrites was detected by 21 dae. Thus, Ab42-induced reduction
of mitochondria in the axons occurs earlier than in the dendrites.
Similar results were obtained from four independent Ab42
transgenic fly lines using the pan-neuronal elav-GAL4 driver
(Figure 1B), or the cholinergic neuron-specific driver, Cha-GAL4
(Figure S1). Reduced mito-GFP signals in neuropil in Ab42 fly
brains were also observed in other brain structures including the
central complex (Figure 1C), which is required for the mainte-
nance of locomotor activity in flies [26].
Mitochondrial mislocalization observed in the Ab42 fly brains is
not due to overexpression of exogeneous protein, since neuronal
expression human a-synuclein [27], which is thought to play a
critical role in Parkinson’s disease, did not induce mislocalization
of mitochondria in the fly brains at 21 dae (Figure S2).
The reduction in mitochondria in the axons and dendrites is
unlikely to be due to degeneration of the mushroom body
structure, since neurodegeneration in the Ab42 fly brain is not
prominent at 5 dae [13,14]. To confirm that the mushroom body
structure has not degenerated, and to test whether Ab42
expression non-specifically alters the protein distribution in axons
and dendrites, we analyzed the distribution of the membrane
protein CD8 fused to a GFP reporter (CD8-GFP). Ab42 did not
cause a noticeable morphological change of the mushroom body
structures or significant reduction in the CD8-GFP signal in axons
or dendrites at 21 dae (Figure 1D).
Mitochondria are transported along microtubules by the motor
proteins. To test whether Ab42-induced mitochondrial mislocaliza-
tion is due to an overall disruption of microtubule-based transport in
neurons, we analyzed distributions of tubulin fused to GFP (tub-
GFP) and the presynaptic protein synaptotagmin fused to GFP (syt-
GFP) in axons and dendrites. Ab42 expression did not result in any
significant difference in the distributions of tub-GFP in axons and
dendrites (Figure 1E) or syt-GFP in axons and cell bodies (Figure 1F)
at 21 dae. These data suggest that Ab42-induced mislocalization of
mitochondria is not due to disorganization of microtubule or global
disruption of axonal transport in neurons.
Mitochondria Are Not Severely Damaged in Young Ab42
Fly Brains
Mitochondrial damage and dysfunction have been shown to
alter mitochondrial localization. We examined whether Ab42
caused severe mitochondrial damage at the ages at which we
observed mitochondrial mislocalization. We compared the
amount of mitochondrial genomes and the levels of ATP in the
brains dissected from control and Ab42 flies, and found that they
were not significantly different (Figure 2A and B). Electron
microscopic (EM) analysis did not detect noticeable alterations in
mitochondrial morphology in the neuropil or cell bodies of
Kenyon cell region in the Ab42 fly brain (Figure 2C). These data
suggest that mitochondrial mislocalization is not due to severe
damage to the mitochondria in the Ab42 fly brain.
Apoptosis can cause mitochondrial fragmentation and fission/
fusion defects, which can result in mitochondrial mislocalization
[28]. Apoptosis was not detected in the Ab42 fly brain by EM
analysis [13] or TUNEL staining (Figure 2D), suggesting that the
Ab42-induced reduction in mitochondria in neurites is not due to
cellular responses associated with apoptosis.
Ab42-Induced Locomotor Deficits Are Enhanced by
Genetic Reduction of Mitochondrial Transport
To test whether mitochondrial mislocalization contributes to
Ab42 toxicity, we examined the effect of a genetic reduction in
mitochondrial transport on Ab42-induced locomotor defects.
Ab42 flies show age-dependent, progressive locomotor dysfunction
starting from 14 dae, which can be detected by climbing assay
[13,14]. In this assay, flies were placed in an empty plastic vial and
tapped to the bottom. The number of flies at the top, middle, or
bottom of the vial was scored after 10 seconds. Mitochondria are
linked to motors by the mitochondrial membrane GTPase Miro,
which is linked to kinesin by milton to allow transport in axons and
dendrites [29]. Null mutations in milton and Miro have been
reported to disrupt axonal and dendritic transport of mitochondria
in neurons [30,31]. Expression of milton RNAi in neurons with
the pan-neuronal elav-GAL4 driver reduced the mRNA levels of
milton in fly heads (Figure 3A), and resulted in 60% reduction in
milton protein levels in dissected fly brains (Figure 3B). We
analyzed mitochondrial localization in the mushroom body
structures to confirm that milton RNAi expression caused a
significant reduction in the mito-GFP signal in axons and an
accumulation in somata (Figure 3C). Using this transgenic RNAi
flies, we found that neuronal knockdown of milton enhanced
Ab42-induced locomotor defects, while milton knockdown itself
did not cause locomotor defects at this age (Figure 3D, left).
Similar results were obtained with the independent transgenic
UAS-milton-RNAi fly line (Figure 3D, right).
A heterozygous Miro mutation (miro[Sd32]) also caused mito-
chondrial mislocalization (Figure 3E) and enhanced locomotor
defects induced by Ab42 (Figure 3F). Locomotor defects were not
observed in the heterozygous miro[Sd32] mutant alone at 20 dae
(Figure 3F). These results suggest that mitochondrial mislocaliza-
tion contributes to Ab42-induced behavioral deficits.
Ab42-Induced Locomotor Deficits Are Modified by cAMP
Levels
cAMP is generated from ATP, and depletion of mitochondria in
axons has been shown to disrupt cAMP/PKA signaling, which limits
mobilization of the synaptic vesicle reserve pool in presynaptic
terminals, and reduces synaptic strength [32]. We tested whether a
reduction in the cAMP level by a genetic reduction of the rutabaga-
encoded type I Ca2+/CaM-dependent adenylyl cyclase (rut) enhanced
neuronal dysfunction in Ab42 flies. Since the rutabaga mutation (rut[1])
is X-linked, we used the cholinergic neuron-specific Cha-GAL4 driver
on the second chromosome, instead of the pan-neuronal elav-GAL4
driver onX choromosome, to drive Ab42 expression inmale flies in the
Ab42 Mislocalizes Mitochondria
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rut[1] background. Expression of Ab42 in cholinergic neurons using the
Cha-gal4 driver caused locomotor defects by 17 dae (Figure 4A, left). In
contrast, in the rutabaga mutant background (rut[1]), Ab42 caused
locomotor dysfunctions by 7 dae (Figure 4A, right). Thus, reduced
cAMP levels result in an earlier onset of Ab42-induced locomotor
defects.
Next, we tested whether an increase in the cAMP level by a
genetic reduction of the dunce-encoded phosphodiesterase (PDE),
Figure 1. Mitochondria are reduced in the axons and dendrites in Ab42 fly brain. (A) A schematic view of the mushroom body. (B) Signal
intensities of mito-GFP in axon bundle tips, dendrites, and cell bodies of the mushroom body structure in control and Ab42 flies at 5 days after
eclosion (dae) and 21 dae. Ratios relative to control are shown (mean6SD, n = 6–10; *, p,0.05, Student’s t-test). Representative images at 21 dae are
shown at the top. (C) Signal intensities of mito-GFP in the central complex, focusing on the ellipsoid body, a circular neuropil region, in control and
Ab42 fly brains at 21 dae. mito-GFP signals are shown as ratios relative to control (mean6SD, n= 3–5; *, p,0.05, Student’s t-test). (D) Signal intensities
of CD8-GFP in axon bundle tips and dendrites in control and Ab42 fly lines at 21 dae are shown as ratios relative to control (mean6SD, n= 6–10). (E)
Signal intensities of tubulin-GFP (tub-GFP) in axon bundle tips and dendrites in controls and Ab42 fly lines at 26 dae are shown as ratios relative to
control (mean6SD, n = 6–10). (F) Signal intensities of synaptotagmin-GFP (syt-GFP) in axon bundle tips and cell bodies in controls and Ab42 fly lines
at 24 dae are shown as ratios relative to control (mean6SD, n= 6–10). (C–E) No significant difference was detected between control and Ab42 fly
brains (p.0.05, Student’s t-test). Male flies with the pan-neuronal elav-GAL4 driver were used for all experiments shown in Figure 1.
doi:10.1371/journal.pone.0008310.g001
Ab42 Mislocalizes Mitochondria
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an enzyme that degrades cAMP, ameliorated neuronal dysfunc-
tion in Ab42 flies. Since the dnc mutation (dnc[1]) is also X-linked,
we used the cholinergic neuron-specific Cha-GAL4 driver on the
second chromosome to drive Ab42 expression in male flies in
dnc[1] mutant background. We found that Ab42-induced locomo-
tor defects were suppressed in flies with a hypomorphic mutation
of dnc (dnc[1]). In contrast, dnc[1] flies show similar locomotor
function as the control flies (See the ‘‘material and methods’’
section for genetic background for dnc[1] and control flies)
(Figure 4B).
Ab42-Induced Locomotor Defects Are Modified by
Neuronal PKA Activity
Since PKA activity is regulated by cAMP levels, we examined
whether PKA activity is involved in Ab42-induced toxicity.
Knockdown of the catalytic subunit of PKA (PKA-C1) in neurons
using UAS-PKA-C1-RNAi driven by the pan-neuronal elav-
GAL4 driver enhanced Ab42-induced locomotor defects, while
neuronal knockdown of PKA-C1 by itself did not cause locomotor
defects at this stage (Figure 4C).
PKA activity is suppressed by binding of the regulatory subunits
(PKA-R) to the catalytic subunit, and overexpression of PKA-R
decreases, while knockdown of PKA-R increases, PKA activity.
The transgenic fly lines EP2162 and EY11550 overexpress PKA-
R2 in neurons when combined with the pan-neuronal elav-GAL4
driver. We found that neuronal overexpression of PKA-R2
significantly enhanced Ab42-induced locomotor defects, while
overexpression of PKA-R2 by itself did not affect locomotor
function (Figure 4D).
We further examined the effects of a reduction in neuronal
PKA-R2 expression on Ab42-induced locomotor dysfunctions.
Knockdown of PKA-R2 in neurons using an RNAi transgene with
the pan-neuronal elav-GAL4 driver suppressed the locomotor
defects in Ab42 flies, while PKA-R2 knockdown by itself did not
affect locomotor function (Figure 4E). Similar results were
observed using an independent Ab42 transgenic fly line (Figure
S3).
Because rut, dnc, and the PKA complex is enriched in the axons
and dendrites in fly neurons [33], these results suggest that
neuronal dysfunctions in Ab42 flies may be attributable to reduced
cAMP/PKA signaling in the axons and dendrites.
Neuronal knock-down of PKA-C1 or PKA-R2 did not affect the
accumulation of Ab42 (Figure S4), the number of Ab42
aggregation detected as Thioflavin S-positive deposits (Figure
S5), or neurodegeneration (Figure S6) in the Ab42 fly brain.
The Levels of Putative PKA Substrate Phosphoproteins
Are Reduced in the Ab42 Fly Brain
To test whether PKA activity is reduced in the Ab42 fly brain,
we compared PKA-C1 and PKA-R2 protein levels and total PKA
activity in extracts from dissected brains from Ab42 and control
flies. These parameters were not significantly different (Figure 5A
and 5B). We next examined whether the cellular distribution of
PKA is altered in the Ab42 fly brain by immunostaining. A strong
PKA-C1 signal was detected in the axons and dendrites, with less
staining in the cell bodies of mushroom body structure. We did not
detect obvious differences between Ab42 and control fly brains
(Figure 5C). We also compared that cAMP levels in head extracts
of Ab42 and control flies, and found they were not significantly
different (Figure 5D and Figure S7).
To further investigate whether the levels of putative PKA
substrate phosphoproteins are reduced in the Ab42 fly brain, we
performed Western blot analysis using a phospho-PKA substrate
Figure 2. Mitochondria are not severely damaged in young
Ab42 fly brains. (A) Quantitation of mitochondrial DNA in the brains
dissected from Ab42 and control flies at 5 dae using quantitative Real
Time-PCR. DNA levels are shown as ratios relative to control (mean6SD,
n = 6). No significant difference was detected (p.0.05, Student’s t-test).
Co I, cytochrome c oxidase subunit I; Co III, cytochrome c oxidase
subunit III, Cyt B, cytochrome b. (B) Quantitation of the ATP levels in the
brains dissected from Ab42 and control flies at 14 dae and 21 dae. ATP
levels are normalized to the protein level (mean6SD). No significant
difference was detected (n = 4; p.0.05, Student’s t-test). (C) Transmis-
sion electron microscopic analysis of mitochondrial morphology in the
neuropil (top) and cell body (bottom) regions of mushroom body
structures in control and Ab42 fly brains at 5 dae. (D) Ab42 fly brains at
25 dae (Ab42) did not contain TUNEL positive cells in Kenyon cell body
region. Nuclei are labeled with Propidium Iodide (magenta). Brains
treated with DNAse were used as a positive control (green). Male flies
with the pan-neuronal elav-GAL4 driver were used for all experiments
shown in Figure 2.
doi:10.1371/journal.pone.0008310.g002
Ab42 Mislocalizes Mitochondria
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Figure 3. Ab42-induced locomotor deficits are enhanced by genetic reductions of mitochondrial transport. (A) Neuronal expression of
the RNAi transgene reduces milton mRNA levels. The milton mRNA levels in heads were quantified by qRT-PCR (n = 6; *p,0.01, Student’s t-test). (B)
Neuronal expression of the RNAi transgene reduces milton protein levels. The milton protein levels in brans were quantified by Western blotting with
anti-Drosophila milton antibody. Signal intensities were quantified, normalized by tubulin levels, and are shown as ratios relative to control
(mean6SD, n = 5; *p,0.05, Student’s t-test). (C) Mislocalization of mitochondria in the mushroom body structure by neuronal knock-down of milton.
Signal intensities of mito-GFP at 15 dae were quantified and are shown as ratios relative to control (mean6SD, n = 6; *, p,0.001, Student’s t-test). (D)
Enhancement of Ab42-induced locomotor defects by neuronal knockdown of milton using UAS-RNAi transgenic fly lines. The average percentage of
flies at the top (white), middle (light gray), or bottom (dark gray) of assay vials is shown (mean6SD, n = 5). Asterisks indicate the significant difference
in the percentage of the flies stayed at the bottom (p,0.05, Student’s t-test). (E) Mislocalization of mitochondria in the miro[Sd32] fly brain. Signal
intensities of mito-GFP at 25 dae were quantified and are shown as ratios relative to control (mean6SD, n= 7–8; *, p,0.0001, Student’s t-test). (F)
Enhancement of Ab42-induced locomotor defects in miro[Sd32] heterozygous background at 14 dae and 25 dae. Asterisks indicate the significant
difference in the percentage of the flies stayed at the bottom (p,0.05, Student’s t-test). Since both the elav-GAL4 and UAS-milton-RNAi are on X
chromosome, female flies were used in Figure 3A, B, C, and the left panel in D. Male flies with the pan-neuronal elav-GAL4 driver were used in the
right panel in D, E and F.
doi:10.1371/journal.pone.0008310.g003
Ab42 Mislocalizes Mitochondria
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antibody (anti-RRxpS/T). We first identified the signals whose
reductions were correlated with the decreased PKA activity in the
dissected fly brains. Neuronal knockdown of PKA-C1 markedly
reduced the signal intensities of phosphoproteins migrating at
24 kDa and 38 kDa (Figure 5E, arrows). Because the identity of
the 24 kDa and 38 kDa proteins is currently under investigation, it
is not clear whether phosphorylation of these proteins is decreased
without changes in the steady-state levels, and these proteins may
be phosphorylated by kinases other than PKA. Nevertheless, since
neuronal knockdown of PKA-C1 markedly reduced these signals,
Figure 4. Ab42-induced locomotor deficits are modified by neuronal cAMP levels and PKA activity. (A) Early onset of Ab42-induced
locomotor defects in the rut[1] background. The climbing ability of male flies expressing Ab42 in the wild type (left) and in the rut[1] background
(right). The Cha-GAL4 driver was used to drive Ab42 expression. Male flies were used. (B) Ab42-induced locomotor defects are suppressed in the dnc
background. The Cha-GAL4 driver was used to drive Ab42 expression. Male flies were used. (C) (Left) Neuronal expression of the RNAi transgene
reduces PKA-C1 protein levels. Western blotting of PKA-C1 in fly head lysates. Tubulin was used to confirm equal protein loading in each lane. (Right)
Enhancement of Ab42-induced locomotor defects by neuronal knockdown of PKA-C1 (Ab42+PKA-C1 RNAi). Neuronal knockdown of PKA-C1 by itself
does not cause locomotor defects. Male flies with the pan-neuronal elav-GAL4 driver were used. (D) (Left) Increased PKA-R2 expression in EP2162 and
EY11550 flies, as shown by Western blotting of PKA-R2 in fly head lysates. (Right) Enhancement of Ab42-induced locomotor defects by
overexpression of PKA-R2. PKA-R2 overexpression by itself does not cause locomotor defects. Male flies with the pan-neuronal elav-GAL4 driver were
used. (E) (Left) Neuronal expression of the RNAi reduces PKA-R2 protein levels, as indicated by Western blotting of PKA-R2 in fly head lysates. (Right)
Amelioration of Ab42-induced locomotor defects by neuronal knockdown of PKA-R2 (PKA-R2 RNAi). PKA-R2 RNAi by itself does not alter climbing
ability. Male flies with the pan-neuronal elav-GAL4 driver were used. Asterisks indicate the significant difference in the percentage of the flies stayed
at the bottom (mean6SD, n = 5, p,0.05, Student’s t-test).
doi:10.1371/journal.pone.0008310.g004
Ab42 Mislocalizes Mitochondria
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the levels of 24 kDa and 38 kDa phosphoproteins are correlated
with PKA activity in the fly brains. We also found that some of the
signals detected by anti-RRxpS/T, including a protein migrating
at 30 kDa, were not affected by PKA-C1 knockdown in fly brains
(Figure 5E, arrowhead).
The signals of the 24 kDa and 38 kDa phosphoproteins were
significantly reduced in the brains dissected from three indepen-
dent Ab42 fly lines (Figure 5F, arrows). In contrast, the signal of
the 30 kDa protein was not affected by Ab42 expression
(Figure 5F, arrowhead). Although we did not detect a change in
overall PKA activity or cAMP levels, these data suggest that
cAMP/PKA signaling is disrupted in the Ab42 fly brain.
In mammals, PKA activates cAMP-response element binding
protein (CREB) via direct phosphorylation at Ser133, and
Drosophila CREB (dCREB) Ser231 is equivalent to the mammalian
Ser133 [34]. dCREB migrates around 38 kDa, and a reduction in
CREB phosphorylation has been reported in cellular and animal
models of AD [35,36]. We tested whether anti-RRxpS/T
recognized phopshorylated dCREB, and whether phosphorylation
of dCREB was affected by Ab42 expression by immunoprecipi-
Figure 5. The levels of putative PKA substrate phosphoproteins are reduced in the Ab42 fly brain. (A) Total protein levels of PKA-C1
(Left) or PKA-R2 (Right) in Ab42 fly brains. Western blot using anti-PKA-C1 or anti-PKA-R2. Signal intensities were quantified and are shown as ratios
relative to control (mean6SD, n= 5; p.0.05, Student’s t-test). (B) PKA activity in brain extracts from control or Ab42 flies at 21 dae. The PKA activity
was normalized to the protein level and is shown as a ratio relative to control. No significant differences were observed (n = 4; p.0.05, Student’s t-
test). (C) Whole-mount immunostaining of brains of control and Ab42 flies at 14dae using anti-PKA-C1 (green). (D) cAMP in head extracts from control
flies and Ab42 fly lines at 25 dae. The amount of cAMP was normalized to total protein. No significant differences were observed (n = 6; p.0.05,
Student’s t-test). A representative standard curve and control experiment are shown in Figure S7. (E) Identification of 24 kDa and 38 kDa proteins
(arrows) as potential PKA substrates in the fly brain. Western blotting of brain lysates from control or PKA-C1 neuronal knockdown flies at 8 dae using
a phospho-PKA substrate antibody (anti-RRxpS/T). The signal intensities were normalized to the tubulin level and are shown as ratios relative to
controls. Asterisks indicate significant differences from control (n = 4; *, p,0.05, Student’s t-test). The signal intensity of the 30 kDa protein
(arrowhead) was not reduced (n = 4; p.0.05, Student’s t-test). (F) The signal intensities of the 24 kDa and 38 kDa proteins (arrows), but not the
30 kDa protein (arrowhead), were reduced in brain extracts of Ab42 fly lines (Ab42-#1–3) at 8 dae. Asterisks indicate significant differences from
control (n = 4; *, p,0.05, Student’s t-test). Male flies with the pan-neuronal elav-GAL4 driver were used in all experiments in Figure 5.
doi:10.1371/journal.pone.0008310.g005
Ab42 Mislocalizes Mitochondria
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tation with anti-RRxpS/T followed by Western blotting with anti-
dCREB antibody. Anti-RRxpS/T recognized phosphorylated
dCREB (Figure 6A), while we did not detect a significant
reduction in dCREB phosphorylation in the Ab42 fly brain
(Figure 6B–C). This result indicates that a reduction of the level of
38 kDa phosphoprotein in the Ab42 fly brain is not due to a
reduction in phosphorylation of dCREB.
Disruption of Mitochondrial Transport Causes Age-
Dependent Behavioral Deficits and Reduces the Levels of
Putative PKA Substrate Phosphoproteins
We have shown that mitochondria are reduced in the axons and
dendrites in the Ab42 fly brain (Figure 1) and that a genetic
reduction in mitochondrial transport enhances Ab42-induced
behavioral deficits (Figure 3). We examined whether a disruption
in mitochondrial transport is sufficient to cause late-onset
behavioral deficits. Neuronal knockdown of milton by UAS-
milton-RNAi driven by the pan-neuronal elav-GAL4 driver did
not affect locomotor function up to 10 dae (Figure 7A, left), but
caused locomotor dysfunctions after 17 dae (Figure 7A, left).
Similar results were obtained with the independent UAS-milton-
RNAi transgenic fly line (Figure 7A, right). In addition, we found
that the levels of the 24 kDa and 38 kDa phosphoproteins were
reduced in the brains dissected from flies with neuronal
knockdown of milton (Figure 7B, arrows), suggesting that
mitochondrial mislocalization causes disruption of cAMP/PKA
signaling.
Discussion
Elucidation of mechanisms underlying Ab42-induced toxicities
is crucial to understanding the complex pathogenesis of AD. An
altered distribution of mitochondria has been reported in the
brains of AD patients and in cellular and animal models of Ab
toxicity [5,6,7,8]. Using a transgenic Drosophila model, we have
demonstrated that mislocalization of mitochondria is induced by
Ab42 without severe mitochondrial damage or neurodegenera-
tion, and that mitochondrial mislocalization underlies neuronal
dysfunction induced by Ab42. Our findings suggest that
mitochondrial mislocalization may contribute to the pathogenesis
of AD.
Mechanisms Underlying Ab42-Induced Mitochondrial
Mislocalization
In Ab42 fly brains, Ab42 is accumulated intraneuronally and
extracellulary [14]. Although it is not yet clear whether
intracellular and/or extracellular Ab42 causes mitochondrial
mislocalization, several possible mechanisms could underlie
mitochondrial mislocalization in Ab42 fly brain neurons.
Some reports have shown that Ab is present within mitochon-
dria and induces mitochondrial damage [7]. Damaged mitochon-
dria are normally transported from neurites to the cell body for
repair or degradation in autophagosomes, and persistent mito-
chondrial damage induced by Ab42 may cause a reduction in
mitochondria in neurites as a result [37]. Indeed, in neurons in the
AD brain, damaged mitochondria accumulate in autophagosomes
in the neuronal cytoplasm [10,11]. In addition, mitochondrial
fragmentation occurs during apoptosis [28], which could be
induced by Ab.
In the Ab42 fly brain, mitochondrial mislocalization occurred
without severe mitochondrial damage (Figure 2). An immunoEM
analysis did not detect Ab42 accumulation in mitochondria in
neurons in the Ab42 fly brain [14]. Moreover, our EM analysis
[13] and TUNEL staining (Figure 2) did not detect apoptosis in
the Ab42 fly brain. These results suggest that severe mitochondrial
damage or apoptosis is not likely to be the primary mechanism
underlying mitochondrial mislocalization in the Ab42 fly brain.
In neurons, mitochondria undergo fission perinuclearly in the
cell body and are transported along microtubule or actin bundles
[24], and global disruption of microtubule-dependent transport
may cause reduced mitochondria in the axons and dendrites.
Axonal swellings that potentially block transport have been
observed in AD mouse models and human AD brains [38], and
Figure 6. Phosphorylation of dCREB is not reduced in head extracts from Ab42 flies at 25 dae. (A) Anti-RRxpS/T detects phosphorylation
of Drosophila CREB (dCREB) at Ser231. dCREB Ser231, the site equivalent to Ser133 of mammalian CREB, is the only RRxpS/T site in dCREB. Head
extracts were subjected to immunoprecipitation using anti-RRxpS/T, followed by Western blotting with anti-dCREB. The specificity of the antibody
was confirmed using loss-of-function dCREB mutant flies (CREBS162). A low level of expression of a dCREB transgene was used to rescue lethality of
CREBS162 (CREBS162+hs-dCREB) [59]. The signal detected by anti-dCREB was reduced in these flies. (B) Head extracts from control flies or from Ab42
flies at 25 dae were subjected to immunoprecipitation using anti-RRxpS/T, followed by Western blotting with anti-dCREB. The phosphorylated CREB
levels were normalized by the CREB level detected by Western blotting of the crude extract and are shown as ratios relative to controls. No difference
in phosphorylated dCREB signal was detected (mean6SD, n = 4; p.0.05). (C) The total CREB level is not altered in Ab42 fly brains. The CREB levels
were normalized by the tubulin levels detected by Western blotting and are shown as ratios relative to controls. (mean6SD, n = 4; p.0.05).
doi:10.1371/journal.pone.0008310.g006
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disruption of axonal transport increases Ab generation [38,39,40].
Ultrastructural studies reveal a loss of the normal microtubular
architecture near intracellular Ab oligomers, which would impair
movement of vesicles and mitochondria [41]. In contrast, it has
also been reported that Ab rapidly impair mitochondrial transport
without affecting mitochondrial function or the cytoskeleton in
hippocampal neurons [42]. In the Ab42 fly brain, mitochondrial
mislocalizaton was observed without significant alterations in
microtubule assembly (Figure 1). In addition, we did not detect
significant changes in the distribution of synaptotagmin-GFP, a
marker for synaptic vesicles (Figure 1). These results suggest that
mitochondrial mislocalization in the Ab42 fly brain is not due to
an overall disruption of microtubule-based transport but may be
due to an altered transport specific to mitochondria.
Mitochondrial transport is regulated by several intracellular
signals. Elevation of intracellular Ca2+, which occurs in regions of
high metabolic demand such as nerve terminals and postsynaptic
specializations, arrests microtubule-based mitochondrial move-
ment. Mitochondria are linked to motors by the mitochondrial
membrane GTPase Miro [29], and a recent study shows that Miro
mediates the Ca22+-dependent arrest of mitochondria [43,44,45].
Since altered Ca2+ homeostasis is observed in AD neurons [46,47],
Ab42 may impair mitochondrial movement by disruption of
signaling that regulates mitochondrial transport to the axons and
dendrites.
The motility of mitochondria is thought to be interrelated with
the fission-fusion machinery and an imbalance between mito-
chondrial fission and fusion induced by Ab42 may result in
reduced mitochondria in the axons and dendrites [32,48,49]. In
AD, mitochondrial size is increased and mitochondrial numbers
are decreased in neurons [10], suggesting that the normally strict
regulation of mitochondrial morphology is impaired. The
dynamin-like GTPase, Drp1, influences mitochondrial density in
axons and dendrites [32,48], and reductions in Drp1 levels or
increases in Drp1 activity by S-nitrosylation are induced by Ab
and detected in AD brains [49,50,51]. Very recent studies showed
that mitochondria are reduced in neuronal processes in AD
neurons [49], presumably due to alterations in the mitochondrial
fission/fusion [49,50,51]. Although we did not detect severe
changes in the morphology of mitochondria in the young Ab42 fly
brain (Figure 2), further morphometric analysis will be required to
determine whether defects in fission and fusion occur and
contribute to the mislocalization of mitochondria in the Ab42 fly
brain.
Dysregulation of the cAMP/PKA Pathway in AD
Impaired regulation of the cAMP/PKA pathway has been
reported in the brains of AD patients. Decreases in levels of
specific adenylyl cyclase (AC) isoforms and disruption of AC/
cAMP signal transduction have been detected in AD brains [52].
Decreased levels of the catalytic and regulatory subunits of PKA,
as well as PKA activity, have also been observed in the brains of
AD patients [53], although other reports did not detect widespread
changes in PKA levels and activity in AD brains [52]. In cellular
and animal models, Ab causes an accumulation of PKA-R by
reducing proteosomal degradation, which leads to a reduction in
PKA activity [36]. In the Ab42 fly brain, levels of putative PKA
substrate phosphoproteins were significantly reduced, however, no
overall changes in PKA protein levels, PKA activity, cAMP levels,
or intracellular localization of the PKA complex were detected
(Figure 5). cAMP is generated from ATP, and it has been shown
that depletion of mitochondria in axons disrupt cAMP/PKA
signaling [32].
Our results suggest that Ab42-induced mitochondrial misloca-
lization causes local, but not global, alterations in cAMP/PKA
activity, such as in the axons and dendrites.
In addition to cAMP/PKA signaling, the loss of ATP caused by
the reduction of mitochondria in neurites could disrupt many
biological processes and lead to neuronal dysfunction. Other
major functions of mitochondria in neurons includes the
regulation of Ca2+, which is important for synaptic plasticity,
and cell survival [37]. Indeed, disrupting mitochondrial transport
diminishes neuronal resistance to NMDA (N-methyl-D-aspartic
acid)-induced excitotoxicity [45]. Thus, mitochondrial mislocali-
zation may contribute to multiple aspects of Ab42 toxicity in the
brain.
Concluding Remarks
Our study demonstrates that mislocalization of mitochondria
underlies Ab42-induced toxicity in vivo. Several reports show that
the loss of mitochondria from axons and dendrites is associated
Figure 7. Disruption of mitochondrial transport causes age-
dependent behavioral deficits and reduces the levels of
putative PKA substrate phosphoproteins. (A) Age-dependent
locomotor defects in the flies with a neuronal knockdown of milton
using UAS-milton RNAi transgenic fly lines. Asterisks indicate the
significant difference in the percentage of the flies stayed at the bottom
(mean6SD, n = 5, p,0.05, Student’s t-test). (B) The signal intensities of
the 24 kDa and 38 kDa (arrows) proteins, but not the 30 kDa
(arrowhead) protein, were reduced in brain extracts of flies with a
neuronal knockdown of milton at 8 dae. The signal intensities were
normalized to the tubulin level and are shown as ratios relative to
controls. Asterisks indicate significant differences from control (n = 4;
*, p,0.05, Student’s t-test). The pan-neuronal elav-GAL4 driver was
used. Since both the elav-GAL4 and UAS-milton-RNAi are on X
chromosome, female flies were used in the left panel in A and B. Male
flies with the elav-GAL4 driver were used in the right panel in A.
doi:10.1371/journal.pone.0008310.g007
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with defective synaptic transmission [30,31,32,48]. AD begins as a
disorder in synaptic function [54], which is believed to be
associated with increased levels of Ab42 in the brain [55]. Studies
in animal models show that these functional deficits predate the
onset of irreversible neurodegenerative damages [3], and restora-
tion of the activities of certain signaling pathways could suppress
Ab42-induced neuronal dysfunctions. For example, rolipram, the
most widely used PDE4 inhibitor, ameliorates memory impair-
ments in APP-PSEN1 double transgenic mice [56]. Thus,
interventions that rescue mitochondrial function, mitochondrial
localization, and associated defects may maintain synaptic
plasticity and neurological function [57]. Further studies of the
physiological and pathophysiological mechanisms that affect
mitochondrial localization may lead to novel approaches for the
prevention and treatment of AD.
Materials and Methods
Fly Stocks and Antibodies
Transgenic fly lines carrying the human Ab42 was established
in the background of the Canton-S w1118 (isoCJ1) genotype as
described in [14]. The elav-GAL4c155 line was outcrossed with the
isoCJ1 flies for 5 generations. The X-linked dnc[1] allele, which was
crossed into a background containing the iso1CJ autosomes, was a
kind gift from Dr. T. Tully (Cold Spring Harbor Laboratory). A
control cross to iso1CJ also was used. Other fly stocks and
antibodies were obtained from: Drs. W. M. Saxton (UAS-mito-
GFP, University of California, Santa Cruz), K. E. Zinsmaier
(miro[Sd32], The University of Arizona), L. Luo (UAS-
CD8::GFP;;OK107, Stanford University), M. B. Feany (UAS-a
synuclein, Harvard Medical School), the Bloomington Drosophila
Stock Center (Indiana University) (elav-GAL4c155, gmr-GAL4,
Cha-GAL4, UAS-tub-GFP, UAS-syt-GFP, rut[1], PKA-R2
[EP2162] and PKA-R2 [EY11150]), the VDRC stock center
(UAS-milton RNAi flies (v41507 (labeled as #2) and v41508
(labeled as #1)), UAS-PKA-C1 RNAi (v6993) and UAS-PKA-R2
RNAi (v39436)) [58], T. L. Schwarz (anti-Drosophila milton,
Harvard Medical School), and D. Kalderon (anti-PKA-C1 and
anti-PKA-R2, Columbia University). A control cross to w1118 from
Bloomington Stock Center or w1118 from VDRC was used for
these flies. Anti-RRxpS/T (Cell Signaling, Beverly, MA) and anti-
tubulin (Sigma, St. Louis, MO) were purchased.
GFP Analysis in Fly Brains
Fly brains were dissected in cold PBS, fixed in PBS containing
4% paraformaldehyde (Electron Microscopy Sciences), and then
placed under vacuum in PBS containing 4% paraformaldehyde
and 0.25% Triton X-100. The fluorescence intensity in the
mushroom body regions was analyzed using a confocal microscope
(Carl Zeiss LSM 510) and quantified using NIH image.
Genomic DNA Extraction and Quantitative Real Time PCR
Analysis
Fly brains were dissected in cold PBS and frozen on dry ice, and
genomic DNA was extracted. 20 brains were homogenated in
100 mM Tris-HCl pH 7.5, 100 mM EDTA, 100 mM NaCl, and
0.5% SDS, and incubate at 65uC for 30 min. Samples were
treated with 1.5 M potassium acetate and 4 M LiCl, and
incubated for 65uC for 30 min, and centrifuged. Supernatant
was treated was phenol/chloroform, added isoprophanol, and
centrifuged. Precipitated gemonic DNA was rinsed with 70%
ethanol and subjected to quantitative real time-PCR (Applied
Biosystems). The average threshold cycle value (Ct) was calculated
from five replicates per sample. Levels of Co I, Co III and CytB
DNA were standardized relative to that of rp49. Relative
expression values were determined by the deltaCt method
according to quantitative PCR Analysis User Bulletin (Applied
Biosystems). Primers were designed using NIH primer blast as
follows: Co I, CTGGAATTGCTCATGGTGGA (forward) and
CTCCCGCTGGGTCAAAAA (reverse); Co III, CCCGCTATT-
GAATTAGGAGCA (forward) and ATTCCGTGGAATC-
CTGTTGC (reverse); CytB, TGAGGTGGATTTGCTGTTGA
(forward) and TGGTTGAATATGGGCAGGTG (reverse); rp49,
GCTAAGCTGTCGCACAAATG (forward) and GTTCGA-
TCCGTAACCGATGT (reverse).
ATP, PKA, and cAMP Assays
ATP contents in dissected brains without eye pigments were
analyzed using ATP Bioluminescence Assay Kit CLSII (Roche,
Mannheim). PKA activity in dissected brains without eye pigments
was measured with MESACUP Protein Kinase Assay Kit (MBL,
Woburn, MA) in the presence or absence of 2 mM cAMP. cAMP
levels was measured with cAMP-screen system (Applied Biosys-
tems, Foster City, CA). ATP, PKA and cAMP levels were
calculated by standard curves and normalized by protein levels.
Transmission Electron Microscopy
Probosces were removed from decapitated heads, which were
then immersion-fixed overnight in 4% glutaraldehyde and 2%
paraformaldehyde in 0.1 M PBS. Samples were post-fixed 1 hr in
ferrocyanide-reduced osmium tetroxide (1% osmium tetroxide and
1.5% potassium ferrocyanide in distilled water). Fixation was
followed by dehydration in a graded ethanol series and infiltration
with Epon-Araldite resin (2 hr in 50% resin in acetone and 24 hr
in 100% resin) using constant rotation. After transferring the
samples to flat-bottom BEEM capsules with fresh resin, the
samples were polymerized overnight at 60uC. Cured blocks
containing fly heads were examined with a dissection microscope
and heads with a suitable orientation (posterior oriented flat to the
block surface) were selected for thin sectioning. Semi thin sections
stained with toluidine blue were examined by light microscopy to
localize the mushroom body region. Thin sections (120 nm) of
entire heads were collected on nickel grids (100 mesh, Veco-EMS).
Thin sections were stained for 5 minutes in lead citrate stain.
Sections were examined and micrographs collected using a
Hitachi H700T TEM.
TUNEL Staining
Fly brains were fixed in PBS containing 4% paraformaldehyde
(Electron Microscopy Sciences, Hatfield, PA), treated with 25 mg/
ml proteinase K for 30 min, and incubated with In Situ Cell
Death Detection Kit, Fluorescein (Roche, Mannheim) for 1 hr at
37uC. The brains were analyzed using a confocal microscope (Carl
Zeiss LSM 510).
RNA Extraction and Quantitative Real Time PCR Analysis
For each sample, 30–40 flies were collected and frozen. Heads
were mechanically isolated, and total RNA was extracted using
TRIzol (Invitrogen) according to the manufacturer’s protocol with
an additional centrifugation step (11,0006g for 10 min) to remove
cuticle membranes prior to the addition of chloroform. Total RNA
was reverse-transcribed using Superscript II reverse transcriptase
(Invitrogen), and the resulting cDNA was used as a template for
PCR on a 7500 fast real time PCR system (Applied Biosystems).
The average threshold cycle value (Ct) was calculated from five
replicates per sample. Expression of milton was standardized
relative to actin. Relative expression values were determined by
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the deltaCt method according to quantitative PCR Analysis User
Bulletin (Applied Biosystems). Primers were designed using NIH
primer blast as follows: milton, CAGGATCAGCTGAAG-
CAACA (forward) and ACACGCTACCTCCCATTGTC (re-
verse); and actin5C, TGCACCGCAAGTGCTTCTAA G (for-
ward) and TGCTGCACTCCAAACTTCCA (reverse).
Western Blotting
Dissected brains were homogenized in Tris-glycine sample
buffer (Invitrogen) and centrifuged at 13,000 rpm for 10 min, and
the supernatants were separated on 6% or 10% Tris-glycine gels
(Invitrogen) and transferred to nitrocellulose membranes (Invitro-
gen). The membranes were blocked with 5% nonfat dry milk
(Nestle´) and blotted with the primary antibody (anti-Drosophila
milton (a gift from Dr. T. L. Schwarz), anti-PKA-C1 (a gift from
Dr. D. Kalderon), anti-PKA-R2 (a gift from Dr. D. Kalderon),
anti-RRxpS/T (Cell Signaling), or anti-tubulin (Sigma)), incubated
with appropriate secondary antibody and developed using ECL
plus Western Blotting Detection Reagents (GE Healthcare).
Climbing Assay
Climbing assay was performed as previously described [14].
Approximately 25 flies were placed in an empty plastic vial. The
vial was gently tapped to knock the flies to the bottom, and the
number of flies at the top, middle, or bottom of the vial was scored
after 10 seconds. Experiments were repeated more than three
times, and a representative result was shown.
Whole-Mount Immunostaining
Fly brains were dissected in cold PBS, fixed in PBS containing
4% paraformaldehyde (Electron Microscopy Sciences), and then
placed under vacuum in PBS containing 4% paraformaldehyde
and 0.25% Triton X-100. After permeabilization with PBS
containing 2% Triton X-100, the brains were stained with rabbit
polyclonal anti-PKA-C1 antibody (a gift from Dr. D. Kalderon)
followed by detection with biotin-XX goat anti-mouse IgG and
streptavidin-Texas Red conjugate (Molecular Probes). The brains
were analyzed using a confocal microscope (Carl Zeiss LSM 510).
Sequential Extraction and Western Blotting of Ab42
For sequential extractions of Ab42, fly heads were homogenized
in RIPA buffer (50 mM Tris-HCl, pH 8.0, 0.5% sodium
deoxycholate, 1% Triton X-100, 150 mM NaCl) containing 1%
SDS. Lysates were centrifuged at 100,0006g for 1 h, and
supernatants were collected (SDS-soluble fraction). SDS-insoluble
pellets were further homogenized in 70% formic acid (Sigma)
followed by centrifugation at 13,000 rpm for 20 min, and the
supernatants were collected (formic acid fraction). Formic acid was
evaporated by SpeedVac (Savant, SC100), and protein was
resuspended in dimethyl sulfoxide (Sigma). Protein extracts were
separated on 10–20% Tris-Tricine gels (Invitrogen) and trans-
ferred to nitrocellulose membranes. The membranes were boiled
in phosphate-buffered saline (PBS) for 3 min, blocked with 5%
nonfat dry milk, blotted with the 6E10 antibody (Signet),
incubated with appropriate secondary antibody and developed
using ECL plus Western Blotting Detection Reagents (GE
Healthcare).
Thioflavin S Staining
For thioflavin S (TS) staining, the dissected brains were
permeabilized and incubated in 50% EtOH containing 0.1% TS
(Sigma) overnight. After washing in 50% EtOH and PBS, the
brains were analyzed using a confocal microscope. The numbers
of TS-positive deposits were quantified from four hemispheres
from three flies per genotype. The fluorescence intensity in
Kenyon cell regions was analyzed using a confocal microscope
(Carl Zeiss LSM 510) and quantified using NIH image.
Quantification of Neurodegeneration
For the analysis of neurodegeneration in Kenyon cell region,
heads were fixed in 4% paraformaldehyde, processed to embed in
paraffin blocks, and sectioned at a thickness of 6 mm. Sections
were placed on slides, stained with hematoxylin and eosin (Vector
Laboratories), and examined by bright field microscopy. To
quantify neurodegeneration, images of the sections were captured,
and the areas of the vacuoles were measured using NIH Image.
Detection of Phosphorylated dCREB by
Immunoprecipitation
dCREB[S162] and the transgenic hs-dCREB2d line are from
Dr. J. C.- P. Yin. Fly heads were homogenized in RIPA buffer
(50 mM Tris?HCl, pH 8.0/0.5% sodium deoxycholate/1% Tri-
ton X-100/150 mM NaCl) containing 1% SDS, centrifuged, and
supernatant was collected. Protein extracts were diluted to 1:10
with RIPA buffer and immunoprecipitated with the anti-RRxpS/
T antibody (Cell Signaling, Beverly, MA), separated on 10% Tris-
Glycine gel (Invitrogen), and blotted with the anti-dCREB
antibody (a gift from Dr. J. C.- P. Yin).
Supporting Information
Figure S1 Mitochondria are mislocalized in cholinergic neurons
in the Ab42 fly brain. Mito-GFP in axon bundle tips, dendrites,
and cell bodies of cholinergic neurons in the mushroom body in
control and Ab42 fly brains. The Cha-GAL4 driver was used to
express transgene in cholinergic neurons. Signal intensities in
control and Ab42 flies at 35 dae were quantified and are shown as
ratios relative to control (mean 6 SD, n= 6–10; *, p,0.05,
Student’s t-test). Representative images are shown at the top. Male
flies were used.
Found at: doi:10.1371/journal.pone.0008310.s001 (0.07 MB
DOC)
Figure S2 a-synuclein did not cause significant alteration of
mitochondria localization in the fly brain. Mito-GFP in axon
bundle tips, dendrites, and cell bodies in the mushroom body in
control and a-synuclein fly brains. Transgene expression was
driven by the pan-neuronal elav-GAL4 driver. Signal intensities in
control and a-synuclein flies at 20 dae were quantified and are
shown as ratios relative to control (mean 6 SD, n= 6–10;
*, p,0.05, Student’s t-test). Representative images are shown at
the top. Male flies were used.
Found at: doi:10.1371/journal.pone.0008310.s002 (0.08 MB
DOC)
Figure S3 Modification of Ab42-induced locomotor defects by
PKA activity was confirmed in an independent Ab42 transgenic
line. (A) Enhancement of Ab42-induced locomotor defects by
neuronal knockdown of PKA-C1 (Ab42+PKA-C1 RNAi). (B)
Enhancement of Ab42-induced locomotor defects by overexpres-
sion of PKA-R2. (C) Suppression of Ab42-induced locomotor
defects by neuronal knockdown of PKA-R2 (PKA-R2 RNAi).
Transgene expression was driven by the pan-neuronal elav-GAL4
driver. The average percentage of flies at the top (white), middle
(light gray), or bottom (dark gray) of the assay vials is shown (mean
6 SD, n= 5). Asterisks indicate the significant difference in the
percentage of the flies stayed at the bottom (p,0.05, Student’s t-
test). Male flies were used.
Ab42 Mislocalizes Mitochondria
PLoS ONE | www.plosone.org 11 December 2009 | Volume 4 | Issue 12 | e8310
Found at: doi:10.1371/journal.pone.0008310.s003 (0.05 MB
DOC)
Figure S4 Accumulation of Ab42 was not affected by neuronal
knockdown of PKA-C1 or PKA-R2 in fly brains. The effect of
neuronal knockdown of PKA-C1 (A) or PKA-R2 (B) on Ab42
accumulation in fly brains. Transgene expression was driven by
the pan-neuronal elav-GAL4 driver. Ab42 in brains from flies at
25 dae in the detergent soluble (RIPA/1%SDS) or insoluble
(70%FA) fraction was detected by Western blotting. Ab42 levels
were normalized to tubulin levels and are shown as ratios relative
to controls. Representative blots are shown on the left, and means
6 SD are plotted on the right. No significant differences were
detected (n= 5; p.0.05, Student’s t-test). Male flies were used.
Found at: doi:10.1371/journal.pone.0008310.s004 (0.08 MB
DOC)
Figure S5 The number of Thioflavin S-positive Ab42-deposits
was not affected by neuronal knockdown of PKA-C1. The effect of
neuronal knockdown of PKA-C1 on the formation of Ab42-
deposits. Thioflavin S (TS) staining of Kenyon cell body regions of
the brain of flies expressing Ab42 in the presence or absence of a
PKA-C1 knockdown at 25 dae. Ab42 expression was driven by the
pan-neuronal elav-GAL4 driver. The numbers of TS-positive
deposits in the Kenyon cell body regions are presented as the
mean 6 SD. No significant difference was detected (n= 4;
p.0.05, Student’s t-test). Male flies were used.
Found at: doi:10.1371/journal.pone.0008310.s005 (0.06 MB
DOC)
Figure S6 Ab42-induced neurodegeneration is not affected by
neuronal knockdown of PKA-C1 or PKA-R2. The effect of
neuronal knockdown of PKA-C1 or PKA-R2 on Ab42-induced
neurodegeneration in fly brains. Transgene expression was driven
by the pan-neuronal elav-GAL4 driver. Representative images of
Kenyon cell bodies in flies expressing Ab42 alone (Top), Ab42 and
PKA-C1 RNAi (Middle), or Ab42 and PKA-R2 RNAi (Bottom) at
28 dae are shown on the left. Neurodegeneration, as reflected by
the presence of vacuoles, is indicated by the arrows. Percentages of
the area lost in the cell body regions are shown as means 6 SD
(n= 7–9 hemispheres). No significant differences from controls
were detected (p.0.05, Student’s t-test). Male flies were used.
Found at: doi:10.1371/journal.pone.0008310.s006 (0.21 MB
DOC)
Figure S7 An example of standard curves and control
experiments for cAMP assay. The cAMP levels were measured
using the cAMP-Screen assay kit (Applied Biosystems) according
to the manufacturer’s instruction. This assay is a competitive
ELISA. Low levels of cAMP result in a high signal, while high
levels result in a low signal. (Top) An example of standard curves.
(Bottom) An example of readings with fly head lysates. Notice that
the well containing fly head lysates without anti-cAMP antibody
produced very low signal.
Found at: doi:10.1371/journal.pone.0008310.s007 (0.04 MB
DOC)
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